Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001104659-23-034573 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-20 | 2023-03-16+ | AMPH | Luo Mary Z. | COO, COB, Chief Scientist, Dir, 10% | F - Tax | $37.10 | -41.0K | 2.08M | -2% | -$1.52M |
| MI | 2023-03-20 | 2023-03-16 | AMPH | Luo Mary Z. | COO, COB, Chief Scientist, Dir, 10% | G - Gift | $0.00 | -114.7K | 0 | -100% | $0 |
| MI | 2023-03-20 | 2023-03-16+ | AMPH | Luo Mary Z. | COO, COB, Chief Scientist, Dir, 10% | F - Tax | $37.06 | -17.1K | 1.46M | -1% | -$631.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-16 | F | D | 25,241 | $37.60 | 2,094,486 | D See footnote | — | — | (F3) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. (F4) Excludes 57,365 shares previously reported as held directly by Dr. Zhang as described in footnote (1) above. (F6) The securities are held of record by Dr. Luo. The reporting persons are husband and wife. |
| 2 | Common | Common Stock | 2023-03-16 | G | D | 57,365 | $0.00 | 0 | I See footnote | — | — | (F1) The shares are held of record by The Jack Y. Zhang 2020 GRAT dated February 7, 2020, Jack Y. Zhang trustee (the "Zhang GRAT"). On February 7, 2020, Dr. Zhang contributed 353,797 shares of directly held Issuer common stock to the Zhang GRAT for the benefit of himself and his three adult children (the "Distributees"). Pursuant to the terms of the Zhang GRAT, upon termination of the Zhang GRAT, 57,365 of the shares were distributed to Distributees. The remaining 296,431 shares representing annuity payments under the Zhang GRAT were previously distributed to Dr. Zhang and continue to be reported in this Form 4 as directly owned by Dr. Zhang. |
| 3 | Common | Common Stock | 2023-03-17 | F | D | 15,768 | $36.29 | 2,078,718 | D | — | — | (F3) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |
| 4 | Common | Common Stock | 2023-03-17 | F | D | 7,052 | $36.29 | 1,455,602 | I | — | — | (F3) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |
| 5 | Common | Common Stock | 2023-03-16 | G | D | 57,365 | $0.00 | 0 | I See footnote | — | — | (F2) The shares are held of record by The Mary Z. Luo 2020 GRAT dated February 7, 2020, Mary Z. Luo trustee (the "Luo GRAT"). On February 7, 2020, Dr. Luo contributed 353,797 shares of directly held Issuer common stock to the Luo GRAT for the benefit of herself and her three adult children (the "Distributees"). Pursuant to the terms of the Luo GRAT, upon termination of the Luo GRAT, 57,365 of the shares were distributed to Distributees. The remaining 296,431 shares representing annuity payments under the Luo GRAT were previously distributed to Dr. Luo and continue to be reported in this Form 4 as directly owned by Dr. Luo. |
| 6 | Common | Common Stock | 2023-03-16 | F | D | 9,998 | $37.60 | 1,462,654 | I See footnote | — | — | (F3) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. (F5) Excludes 57,365 shares previously reported as held directly by Dr. Luo as described in footnote (2) above. (F6) The securities are held of record by Dr. Luo. The reporting persons are husband and wife. |